Outlook for Biotech Financing in 2022

User Review
0 (0 votes)

The Biotech market has seen an unprecedented influx of funding and IPOs have also reached record levels in 2020 and 2021. But things have started to change: in the second half of 2021, Biotech IPOs significantly slowed down, and as the Fed tees up rate increases for March, the financing environment in 2022 is likely to look different than it did a year or two ago.